UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030396
Receipt number R000034576
Scientific Title Prospective study on early diagnosis of Parkinson's disease in medical checkup examinees with non-motor symptoms
Date of disclosure of the study information 2018/01/01
Last modified on 2018/06/19 11:47:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study on early diagnosis of Parkinson's disease in medical checkup examinees with non-motor symptoms

Acronym

NaT-PROBE

Scientific Title

Prospective study on early diagnosis of Parkinson's disease in medical checkup examinees with non-motor symptoms

Scientific Title:Acronym

NaT-PROBE

Region

Japan


Condition

Condition

Parkinson's disease
Dementia with Lewy Bodies

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To evaluate the incidence of Parkinson's disease between the two groups
1) examinees of medical checkups who have two or more non-motor symptoms
2) examinees of medical checkups without non-motor symptoms

Basic objectives2

Others

Basic objectives -Others

Diagnosis

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of Parkinson's disease during the 10 year follow-up period

Key secondary outcomes

Changes in H/M ratio of MIBG scintigraphy during the 10 year follow-up period
Changes in SBR of DaT scan during the 10 year follow-up period


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Skin biopsy, MIBG scintigraphy and DaT scan

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Examinees of medical checkups who answered the questionnaire about non-motor symptoms of Parkinson disease
Subjects who can make a outpatient visit regularly
Subjects who agreed to participate in this study
Subjects who fulfill one of the following criteria
1) participants who have two or more non-motor symptoms: SCOPAAUT, 9 or more; SAOQ, 85 or less; RBDSQ, 4 or more.
2) participants who don't have any non-motor symptoms: SCOPA-AUT, SAOQ, RBDSQ, BDI-2 and JESS scores are all normal.

Key exclusion criteria

Subjects who have mental and neurological disorders other than depression
Subjects who are inappropriate to participate in the study

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahisa Katsuno

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Neurology

Zip code


Address

65, Tsurumai-cho, Showa-ku, Nagoya city, Aichi, Japan

TEL

052-744-2391

Email

ka2no@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Makoto Hattori

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Neurology

Zip code


Address

65, Tsurumai-cho, Showa-ku, Nagoya city, Aichi, Japan

TEL

052-744-2391

Homepage URL


Email

makochan.0401@gmail.com


Sponsor or person

Institute

Nagoya University, Department of Neurology

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 11 Month 10 Day

Date of IRB


Anticipated trial start date

2018 Year 02 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2029 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 12 Month 14 Day

Last modified on

2018 Year 06 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034576


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name